The Nutshell

» clinical trials

Daily News Roundup

Most Recent

image: Cannabidiol Quells Seizures

Cannabidiol Quells Seizures

By | April 14, 2015

The marijuana-derived compound shows promise in treating rare forms of epilepsy that cause children to have seizures multiple times a day.

0 Comments

image: Ebola Vaccines Protect Monkeys

Ebola Vaccines Protect Monkeys

By | April 9, 2015

Two new Ebola vaccine candidates prove safe and effective against the virus in macaques, a study shows.

0 Comments

image: Ebola Vax Trial Update

Ebola Vax Trial Update

By | March 26, 2015

A novel Ebola vaccine being tested in China is safe and provokes a notable immune response in people, according to a Phase 1 trial.

0 Comments

image: Clinic Trial Problems Kept Mum

Clinic Trial Problems Kept Mum

By | February 11, 2015

Despite documented dysfunction in a number of studies, rarely do those problems get a mention in the resulting publications, according to a new study.

0 Comments

image: Ebola Drug Trial Canceled

Ebola Drug Trial Canceled

By | February 2, 2015

As the number of Ebola cases declines, Chimerix is unable to recruit enough patients for its trial in Liberia testing the antiviral drug brincidofovir.

0 Comments

image: Tamiflu Reviewed Again

Tamiflu Reviewed Again

By | January 30, 2015

The controversial antiviral drug earns better marks in the most recent analysis of the evidence. 

1 Comment

image: Ebola Update

Ebola Update

By | January 26, 2015

Vaccine trial to start in Liberia as early as next week; trial for experimental therapy also planned, but production is still limited

1 Comment

image: IOM Urges Data Sharing

IOM Urges Data Sharing

By | January 15, 2015

The Institute of Medicine says results from human clinical trials ought to be made available to independent researchers within 18 months.

0 Comments

image: 23andMe Partners with Pfizer

23andMe Partners with Pfizer

By | January 13, 2015

The personal genomics company strikes yet another deal to glean biomedically relevant information from its user data.

1 Comment

image: Spinoff Company to Develop Rare Disease Drugs

Spinoff Company to Develop Rare Disease Drugs

By | January 7, 2015

Maryland-based Vtesse will work with the US National Institutes of Health to advance treatments for Niemann-Pick Type C disease and other lysosomal storage disorders.

1 Comment

Popular Now

  1. A Coral to Outlast Climate Change
  2. Science Celebrities: Where Are the Women?
  3. First In Vivo Human Genome Editing to Be Tested in New Clinical Trial
  4. Understanding Body Ownership and Agency
AAAS